Jeffrey Davis
Family Medicine · Wichita, KSNPI 1285675413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 153 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$579
- AbbVie$365
- Amgen$270
- Novo Nordisk$165
- AstraZeneca$154
- Amarin Pharma, Inc.$125
- plus $1K from 32 others
Across 6 payments — averaging $27,689 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$160K
- Sunovion Pharmaceuticals Inc.$6K
What the payments were for
- Food & beverage$3,151100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 37 | $579 |
| AbbVie(2 entities) | 17 | $365 |
| Amgen | 14 | $270 |
| Novo Nordisk | 4 | $165 |
| AstraZeneca | 5 | $154 |
| Amarin Pharma, Inc. | 1 | $125 |
| Medtronic | 1 | $123 |
| Abbott | 7 | $122 |
| IBSA Pharma Inc. | 6 | $115 |
| Antares Pharma, Inc. | 6 | $106 |
| Urovant Sciences Inc | 5 | $79 |
| Clarus Therapeutics Inc. | 1 | $75 |
| Astellas Pharma US Inc | 4 | $65 |
| Dexcom, Inc. | 2 | $65 |
| Evofem Biosciences, Inc. | 4 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| QOL Medical, LLC | 3 | $58 |
| Johnson & Johnson | 3 | $56 |
| Tolmar Pharmaceuticals, Inc. | 4 | $55 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Dendreon Pharmaceuticals LLC | 2 | $40 |
| Nestle Healthcare Nutrition Inc. | 2 | $39 |
| Pfizer | 2 | $35 |
| Exact Sciences | 2 | $33 |
| Lilly USA, LLC | 2 | $26 |
| Calyxo, Inc. | 1 | $26 |
| Novartis | 1 | $26 |
| Eisai Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Coloplast | 1 | $16 |
| Accord Healthcare, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,151 in reported general payments places this provider in the 80th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armour ThyroidThyroid,pork | 39 | $2,579 |
| SynthroidLevothyroxine Sodium | 26 | $2,427 |
| TirosintLevothyroxine Sodium | 11 | $1,514 |
| ProgesteroneProgesterone, Micronized | 54 | $1,348 |
| Np ThyroidThyroid,pork | 24 | $1,177 |
| Ezetimibe | 47 | $962 |
| Levothyroxine Sodium | 90 | $665 |
| Potassium Chloride | 23 | $558 |
| Tamsulosin Hcl | 44 | $549 |
| Acyclovir | 12 | $529 |
| Liothyronine Sodium | 16 | $522 |
| Nebivolol Hcl | 13 | $488 |
| Rosuvastatin Calcium | 77 | $382 |
| Chlorthalidone | 21 | $336 |
| Allopurinol | 50 | $308 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieArmour Thyroid, Synthroid | $365 | $5,00665 claims |
| IBSA Pharma Inc.Tirosint | $115 | $1,51411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Joseph SackWichita$21K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.